{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:31:49Z","timestamp":1791232309866,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.eplepsyres.2012.06.004","type":"journal-article","created":{"date-parts":[[2012,7,18]],"date-time":"2012-07-18T11:16:47Z","timestamp":1342610207000},"page":"201-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Sodium valproate for epilepsy in rural China: An efficacy and safety assessment in primary care"],"prefix":"10.1016","volume":"102","author":[{"given":"Wenzhi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinou","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suiqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josemir W.","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.","key":"10.1016\/j.eplepsyres.2012.06.004_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2006.00666.x","article-title":"Role of valproate across the ages. Treatment of epilepsy in children","volume":"184","author":"Aldenkamp","year":"2006","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2012.06.004_bib0010","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.48.1.182","article-title":"Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration\u2013response design clinical trial. Depakote Monotherapy for Partial Seizures Study Group","volume":"48","author":"Beydoun","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2012.06.004_bib0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0920-1211(92)90059-3","article-title":"Conventional and controlled release valproate in children with epilepsy: a cross-over study comparing plasma levels and cognitive performances","volume":"13","author":"Brouwer","year":"1992","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.06.004_bib0020","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2165\/00003495-199447020-00008","article-title":"Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy","volume":"47","author":"Davis","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.eplepsyres.2012.06.004_bib0025","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S1474-4422(06)70528-2","article-title":"Premature mortality in people with epilepsy in rural China: a prospective study","volume":"5","author":"Ding","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2012.06.004_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14656566.9.2.285","article-title":"Oral valproic acid for epilepsy \u2013 long-term experience in therapy and side effects","volume":"9","author":"Gerstner","year":"2008","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.eplepsyres.2012.06.004_bib0035","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1136\/jnnp.2004.045690","article-title":"The natural history of epilepsy: an epidemiological view","volume":"75","author":"Kwan","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2012.06.004_bib0040","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2012.06.004_bib0045","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1528-1157.2001.32800.x","article-title":"ILAE Commission on the Developing World. The treatment gap in epilepsy: the current situation and ways forward","volume":"42","author":"Meinardi","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.06.004_bib0050","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.0b013e318223c784","article-title":"Causes of death among people with convulsive epilepsy in rural West China: a prospective study","volume":"77","author":"Mu","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2012.06.004_bib0055","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","article-title":"Estimation of the burden of active and life-time epilepsy: a meta-analytic approach","volume":"51","author":"Ngugi","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.06.004_bib0060","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eplepsyres.2012.06.004_bib0065","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00019052-200304000-00008","article-title":"The epidemiology of epilepsy revisited","volume":"16","author":"Sander","year":"2003","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.eplepsyres.2012.06.004_bib0070","first-page":"549","article-title":"Comparison of phenobarbitone, phenytoin with sodium valproate: randomized, double-blind study","volume":"33","author":"Thilothammal","year":"1996","journal-title":"Indian Pediatr."},{"issue":"9","key":"10.1016\/j.eplepsyres.2012.06.004_bib0075","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1212\/01.WNL.0000059867.35547.DE","article-title":"The prevalence and treatment gap in epilepsy in China","volume":"60","author":"Wang","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2012.06.004_bib0080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1474-4422(05)70254-4","article-title":"Efficacy assessment of phenobarbital in epilepsy: a large community-based intervention trial in rural China","volume":"5","author":"Wang","year":"2006","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.eplepsyres.2012.06.004_bib0085","doi-asserted-by":"crossref","first-page":"964","DOI":"10.2471\/BLT.07.047050","article-title":"Global campaign against epilepsy: assessment of a demonstration project in rural China","volume":"86","author":"Wang","year":"2008","journal-title":"Bull. World Health Organization"},{"key":"10.1016\/j.eplepsyres.2012.06.004_bib0090","series-title":"Epilepsy Management at a Primary Health Level: Protocol for a Demonstration Project in the People's Republic of China","author":"WHO","year":"2000"},{"key":"10.1016\/j.eplepsyres.2012.06.004_bib0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0002-9343(88)90050-2","article-title":"Review of valproate monotherapy in the treatment of generalized tonic\u2013clonic seizures","volume":"84","author":"Wilder","year":"1988","journal-title":"Am. J. Med."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121112001726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121112001726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:27:43Z","timestamp":1760275663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121112001726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0920121112001726"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.06.004","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium valproate for epilepsy in rural China: An efficacy and safety assessment in primary care","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}